Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Rank in Stocks #20647
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Share Price
$0.517
Last synced: 2026-08-21
Market Cap
$125.14M
Change (1 day)
-0.58%
Change (1 year)
47.71%
Country
US
Trade Vaxart, Inc. (VXRT)

Category

Stock price history for Vaxart, Inc. (VXRT)
Highest end of day price: $0.54 on 2026-08-01

Lowest end of day price: $93.11 on 1981-12-01
Stock price history of Vaxart, Inc. from 1981 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 46.78%
2025 -40.84%
2024 -5.29%
2023 -36.66%
2022 -84.42%
2021 -8.81%
2020 2,164.33%
2019 -87.67%
2018 -59.95%
2017 -54.04%
2016 -35.58%
2015 -12.95%
2014 -44.23%
2013 -0.82%
2012 -63.27%
2011 -66.84%
2010 11.78%
2009 44.58%
2008 -4.77%
2007 -47.85%
2006 98.68%
2005 -76.37%
2004 32.53%
2003 72.81%
2002 -34.23%
2001 142.99%
2000 -8.21%
1999 63.47%
1998 -25.43%
1997 -61.94%
1996 -1.29%
1995 40.51%
1994 119.96%
1993 5.65%
1992 -17.87%
1991 266.03%
1990 29.50%
1989 -17.75%
1988 0.26%
1987 -37.28%
1986 45.28%
1985 11.99%
1984 -51.20%
1983 6.47%
1982 23.65%
1981 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.26 -15.20%
AU
$770.19 8.98%
CH